# Phase 1 Safety and PK Study of OLT1177 Capsules

> **NCT02134964** · PHASE1 · COMPLETED · sponsor: **Olatec Therapeutics LLC** · enrollment: 35 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** OLT1177 Capsules
- **DRUG:** Placebo Capsules

## Key facts

- **NCT ID:** NCT02134964
- **Lead sponsor:** Olatec Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02134964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02134964, "Phase 1 Safety and PK Study of OLT1177 Capsules". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02134964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*